Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Asia-Pacific biotechnology market had total revenues of $249.9 billion in 2021, representing a compound annual growth rate (CAGR) of 15.2% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $126.5 billion, equivalent to 50.6% of the market's overall value.
- The Indian market is the largest in the Asia-Pacific region, accounting for 38% of its total value in 2021. The Indian market has experienced some of the strongest growth rates in the region in recent years, as it develops in maturity.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Asia-Pacific biotechnology market by value in 2021?
- What will be the size of the Asia-Pacific biotechnology market in 2026?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in Asia-Pacific's biotechnology market?
Frequently Asked Questions about the Asia-Pacific Biotechnology Market
What is the estimated value of the Asia-Pacific Biotechnology Market?
What is the growth rate of the Asia-Pacific Biotechnology Market?
What is the forecasted size of the Asia-Pacific Biotechnology Market?
Who are the key companies in the Asia-Pacific Biotechnology Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 46 |
| Published | October 2022 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 249.85 Billion |
| Forecasted Market Value ( USD | $ 623.05 Billion |
| Compound Annual Growth Rate | 20.0% |
| Regions Covered | Asia Pacific |
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Takeda Pharmaceutical Company Limited
- Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
- Shanghai Kehua Bio-engineering Co Ltd
- Astellas Pharma Inc.
